National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 10) (PB 119 of 2020) (Cth)
PB 119 of 2020
National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 10)
I, Thea Connolly, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make the following Determination.
Dated 26 November 2020
THEA CONNOLLY
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
Contents
1 Name........................................................................................................................................ 1
2 Commencement........................................................................................................................ 1
3 Authority.................................................................................................................................. 1
4 Schedules................................................................................................................................. 1
Schedule 1—Amendments 2
National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010) 2
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 10).
This instrument may also be cited as PB 119 of 2020
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
| Commencement information | ||
| Column 1 | Column 2 | Column 3 |
| Provisions | Commencement | Date/Details |
| 1. The whole of this instrument | 1 December 2020. | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
1 Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besilate)
omit from the column headed “Claimed Price”: 9.38 substitute: 11.24
2 Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besilate)
omit from the column headed “Claimed Price”: 10.03 substitute: 11.89
3 Schedule 1, entry for Amlodipine with atorvastatin in the form Tablet 5 mg amlodipine (as besilate) with 40 mg
omit from the column headed “Claimed Price”: 6.57 substitute: 8.43
4 Schedule 1, entry for Amlodipine with atorvastatin in the form Tablet 5 mg amlodipine (as besilate) with 80 mg
omit from the column headed “Claimed Price”: 7.84 substitute: 9.70
5 Schedule 1, entry for Amlodipine with atorvastatin in the form Tablet 10 mg amlodipine (as besilate) with 10 mg
omit from the column headed “Claimed Price”: 5.68 substitute: 7.54
6 Schedule 1, entry for Amlodipine with atorvastatin in the form Tablet 10 mg amlodipine (as besilate) with 20 mg
omit from the column headed “Claimed Price”: 6.36 substitute: 8.22
7 Schedule 1, entry for Amlodipine with atorvastatin in the form Tablet 10 mg amlodipine (as besilate) with 40 mg
omit from the column headed “Claimed Price”: 7.21 substitute: 9.07
8 Schedule 1, entry for Amlodipine with atorvastatin in the form Tablet 10 mg amlodipine (as besilate) with 80 mg
omit from the column headed “Claimed Price”: 8.48 substitute: 10.34
9 Schedule 1, omit entry for Erythromycin
10 Schedule 1, after entry for Exemestane
Insert
| Ezetimibe | Tablet 10 mg | Ezetrol | 30 | 12.71 | 15.50 |
| Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Rosuzet Composite Pack | 1 | 14.27 | 17.06 |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Rosuzet Composite Pack | 1 | 15.02 | 17.81 | |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Rosuzet Composite Pack | 1 | 15.96 | 18.75 | |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Rosuzet Composite Pack | 1 | 17.35 | 20.14 |
11 Schedule 1, entry for Labetalol
Omit
| Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral | Trandate | 100 | 12.32 | 15.58 |
| Tablet containing labetalol hydrochloride 200 mg | Oral | Trandate | 100 | 12.32 | 15.58 |
Substitute
| Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral | Trandate | 100 | 12.32 | 15.58 |
12 Schedule 1, omit entry for Methyldopa
13 Schedule 1, omit entry for Minocycline
14 Schedule 1, entry for Naproxen
Omit
| Naproxen | Tablet 250 mg | Oral | Naprosyn | 50 | 3.38 | 4.42 |
| Tablet 500 mg | Oral | Naprosyn | 50 | 4.99 | 6.04 | |
| Tablet 1 g (sustained release) | Oral | Naprosyn SR1000 | 28 | 6.10 | 7.14 | |
| Tablet 750 mg (sustained release) | Oral | Naprosyn SR750 | 28 | 4.58 | 5.56 | |
| Tablet containing naproxen sodium 550 mg | Oral | Anaprox 550 | 50 | 5.13 | 6.89 |
Substitute
| Naproxen | Tablet 1 g (sustained release) | Oral | Naprosyn SR1000 | 28 | 6.10 | 7.14 |
| Tablet 750 mg (sustained release) | Oral | Naprosyn SR750 | 28 | 4.58 | 5.56 | |
| Tablet containing naproxen sodium 550 mg | Oral | Anaprox 550 | 50 | 5.13 | 6.89 |
15 Schedule 1, omit entry for Nitrazepam
16 Schedule 1, entry for Oxazepam
Omit
| Oxazepam | Tablet 15 mg | Oral | Serepax | 25 | 1.32 | 3.79 |
| Tablet 30 mg | Oral | Serepax | 25 | 1.00 | 3.17 |
Substitute
| Oxazepam | Tablet 30 mg | Oral | Serepax | 25 | 1.00 | 3.17 |
17 Schedule 1, entry for Rosuvastatin in the form Tablet 10 mg (as calcium)
omit from the column headed “Claimed Price”: 4.39 substitute: 5.16
0
0
0